Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
etonogestrel + testosterone undecanoate
- Development stage
- Unknown
- Lead developer
- Organon
- Modality
- Small Molecules
- Administration
- Subcutaneous, Intramuscular
01
Overview
Etonogestrel + testosterone undecanoate is an investigational combination of a progestin (etonogestrel) and an androgen (testosterone undecanoate) studied for use as a male hormonal contraceptive. Etonogestrel is a long-acting synthetic progestin commonly used in contraceptive implants, while testosterone undecanoate is an esterified form of testosterone used for hormone replacement therapy in hypogonadal men. The combination works by suppressing spermatogenesis through negative feedback on the hypothalamic-pituitary-gonadal axis, reducing endogenous gonadotropin secretion and thus sperm production. Clinical studies have shown that this regimen can induce rapid and consistent suppression of sperm counts to levels compatible with effective contraception[8][4][2]. This approach aims to provide reversible, reliable male contraception.
- Other names
- etonogestrel + testosterone undecanoate
02
Targets
PR (Progesterone receptor)AR (Adrenergic receptors)
Beyond the preview
Go deeper on etonogestrel + testosterone undecanoate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on etonogestrel + testosterone undecanoate.